Heparin-coated cardiopulmonary bypass circuit: Clinical effects in pediatric cardiac surgery

被引:16
|
作者
Miyaji, K [1 ]
Hannan, RL [1 ]
Ojito, J [1 ]
Jacobs, JP [1 ]
White, JA [1 ]
Burke, RP [1 ]
机构
[1] Miami Childrens Hosp, Dept Cardiovasc Surg, Miami, FL USA
关键词
D O I
10.1111/j.1540-8191.2000.tb00456.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Heparin-coated cardiopulmonary bypass (CPB) circuits have been reported to reduce complement activation and the inflammatory response associated with CPB. We retrospectively compared patients utilizing heparin-coated perfusion circuits with those using noncoated circuits to determine the clinical effects of the different circuits in pediatric cardiac surgery. Methods: Between July 1995 and July 1997, 203 patients weighing < 10 kg underwent cardiac surgery, 153 patients using heparin-coated bypass circuits and 50 patients using noncoated circuits. The 50 patients operated on with the noncoated circuit (Group N) were matched to 100 patients operated on with coated circuits (Group H) in age, weight, and type of procedure. Urine output during bypass, blood products used after bypass, postoperative ventilation days, hospital stay, morbidity, and mortality were compared between these groups. Results: Body weight, perfusion time, and procedure time were not different between the two groups. Urine output during bypass was notably greater in Group H than in Group hi (11.3 +/- 10.5 mL/kg per hour vs 4.8 +/- 3.1 mL/kg per hour, respectively, p < 0.0001). Postoperative mechanical ventilation markedly decreased in Group H (Group H vs hi = 2.8 +/- 2.7 days vs 5.1 +/- 7.5 days, respectively, p < 0.05). Red blood cell usage, hospital stay, morbidity, and mortality were not statistically different, although there was a tendency toward decreased transfusion of red cell and platelets in Group H (Group H vs N = 61.2 +/- 121.1 mL/kg vs 102.0 +/- 176.7 mL/kg, respectively, in red cell, p = 0.15; and Group H vs hi = 7.9 +/- 13.7 mL/kg vs 13.2 +/- 24.5 mL/kg, respectively, in platelets, p = 0.16). Conclusions: Patients operated on with the use of heparin-coated circuits had increased urine output during bypass and required less time postoperatively on the ventilator. These results suggest a reduction in the acute inflammatory response, capillary leakage, and overall systemic edema. We now routinely use coated circuits on all pediatric pump cases.
引用
收藏
页码:194 / 198
页数:5
相关论文
共 50 条
  • [31] Protective effect of heparin-coated circuits on the platelets during cardiopulmonary bypass
    Zhang Kailun
    Hu Zhiwei
    Yang Yunhai
    Huang Ruqing
    Fan Huiming
    Sun Zongquan
    Current Medical Science, 2003, 23 (4) : 403 - 406
  • [32] BIOCOMPATIBILITY OF HEPARIN-COATED MEMBRANE-OXYGENATOR DURING CARDIOPULMONARY BYPASS
    HATORI, N
    YOSHIZU, H
    HAGA, Y
    KUSAMA, Y
    TAKESHIMA, S
    SEGAWA, D
    TANAKA, S
    ARTIFICIAL ORGANS, 1994, 18 (12) : 904 - 910
  • [33] The impact of heparin-coated circuits on hemodynamics during and after cardiopulmonary bypass
    de Vroege, R
    Huybregts, R
    van Oeveren, W
    van Klarenbosch, J
    Linley, G
    Mutlu, J
    Jansen, E
    Hack, E
    Eijsman, L
    Wildevuur, C
    ARTIFICIAL ORGANS, 2005, 29 (06) : 490 - 497
  • [34] Poly-2-methoxyethylacrylate-coated cardiopulmonary bypass circuit can reduce transfusion of platelet products compared to heparin-coated circuit during aortic arch surgery
    Hosoyama, Katsuhiro
    Ito, Koki
    Kawamoto, Shunsuke
    Kumagai, Kiichiro
    Akiyama, Masatoshi
    Adachi, Osamu
    Kawatsu, Satoshi
    Sasaki, Konosuke
    Suzuki, Marina
    Sugawara, Yumi
    Shimizu, Yuya
    Saiki, Yoshikatsu
    JOURNAL OF ARTIFICIAL ORGANS, 2016, 19 (03) : 233 - 240
  • [35] High and low heparin dose with heparin-coated cardiopulmonary bypass: Activation of complement and granulocytes
    Ovrum, E
    Mollnes, TE
    Fosse, E
    Holen, EA
    Tangen, G
    Ringdal, MAL
    Videm, V
    ANNALS OF THORACIC SURGERY, 1995, 60 (06): : 1755 - 1761
  • [36] Poly-2-methoxyethylacrylate-coated cardiopulmonary bypass circuit can reduce transfusion of platelet products compared to heparin-coated circuit during aortic arch surgery
    Katsuhiro Hosoyama
    Koki Ito
    Shunsuke Kawamoto
    Kiichiro Kumagai
    Masatoshi Akiyama
    Osamu Adachi
    Satoshi Kawatsu
    Konosuke Sasaki
    Marina Suzuki
    Yumi Sugawara
    Yuya Shimizu
    Yoshikatsu Saiki
    Journal of Artificial Organs, 2016, 19 : 233 - 240
  • [37] Protective effect of heparin-coated circuits on the platelets during cardiopulmonary bypass
    Zhang, Kailun
    Hu, Zhiwei
    Yang, Yunhai
    Huang, Ruqing
    Fan, Huiming
    Sun, Zongquan
    Journal of Huazhong University of Science and Technology - Medical Science, 2003, 23 (04): : 403 - 406
  • [38] Protective Effect of Heparin-coated Circuits on the Platelets during Cardiopulmonary Bypass
    张凯伦
    胡志伟
    杨运海
    黄如清
    范慧敏
    孙宗全
    华中科技大学学报(医学英德文版), 2003, (04) : 403 - 406
  • [39] HEPARIN-COATED CIRCUITS REDUCE ACTIVATION OF GRANULOCYTES DURING CARDIOPULMONARY BYPASS - A CLINICAL-STUDY
    BOROWIEC, J
    THELIN, S
    BAGGE, L
    NILSSON, L
    VENGE, P
    HANSSON, HE
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1992, 104 (03): : 642 - 647
  • [40] Haemostasis at low heparin dosage during cardiopulmonary bypass with heparin-coated circuits in pigs
    Bagge, L
    Borowiec, JW
    Thelin, S
    Hultman, J
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 1997, 31 (05) : 275 - 281